What is NDC 17312-019?

17312-019 is the product NDC for Irritable Bowel Syndrome Therapy, Asafetida 3 [hp_X]/1 + 7 more ingredients tablet, orally disintegrating, listed with the FDA by TRP Company. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Irritable Bowel Syndrome Therapy (Asafetida - bismuth subnitrate - bryonia alba root - activated charcoal - lycopodium clavatum spore - sodium carbonate - strychnos nux-vomica seed - veratrum album root -).

What is the active ingredient?

Asafetida, Bismuth subnitrate, Bryonia alba root, Activated charcoal, Lycopodium clavatum spore, Sodium carbonate, Strychnos nux-vomica seed, Veratrum album root.

TRP Company, NDC labeler code 17312. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Irritable Bowel Syndrome Therapy?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Irritable Bowel Syndrome Therapy NDC 17312-019

NDC codes

FDA NDC Directory

Product NDC (as listed)17312-019Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17312-0019Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
17312-019-14	17312001914	1 BOTTLE in 1 PACKAGE (17312-019-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLEMarketed from May 5, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Irritable Bowel Syndrome Therapy
Generic name (nonproprietary): asafetida - bismuth subnitrate - bryonia alba root - activated charcoal - lycopodium clavatum spore - sodium carbonate - strychnos nux-vomica seed - veratrum album root -
Active ingredients: Asafetida — 3 [hp_X]/1Bismuth subnitrate — 6 [hp_X]/1Bryonia alba root — 6 [hp_X]/1Activated charcoal — 6 [hp_X]/1Lycopodium clavatum spore — 6 [hp_X]/1Sodium carbonate — 6 [hp_X]/1Strychnos nux-vomica seed — 6 [hp_X]/1Veratrum album root — 6 [hp_X]/1
Dosage form: Tablet, Orally disintegrating
Route: Oral
Labeler: TRP CompanyNDC labeler code 17312
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Dec 1, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Allergens (Chemical structure)Bismuth (Chemical structure)Cell-mediated Immunity (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased IgG Production (Physiologic effect)Plant Proteins (Chemical structure)Seed Storage Proteins (Chemical structure)
Identifiers: Product ID 17312-019_46052231-af53-3dfd-e063-6394a90a71ffSPL ID 46052231-af53-3dfd-e063-6394a90a71ffSPL set ID 04149220-c7ce-4312-9630-f93d6def3aaaUNII W9FZA51AS1, H19J064BA5, T7J046YI2B, 2P3VWU3H10, C88X29Y479, 45P3261C7T, 269XH13919, QNS6W5US1ZUPC 0858961001198
Pharmacologic class: Bismuth; Non-Standardized Plant Allergenic Extract

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N417312001914 followed by a unit qualifier and the quantity

Package 17312-0019-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 15, 2025.

Indications (excerpt from the label)

Indications and usage Uses:* According to homeopathic indications these ingredients temporarily relieve symptoms such as: • loose stools • bloating • dry, hard stools • cramping • irritability • flatulence • irregularity • stomach discomfort after a diagnosis by a physician. *These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 17312-019

What is NDC 17312-019?: 17312-019 is the product NDC for Irritable Bowel Syndrome Therapy, Asafetida 3 [hp_X]/1 + 7 more ingredients tablet, orally disintegrating, listed with the FDA by TRP Company. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Irritable Bowel Syndrome Therapy (Asafetida - bismuth subnitrate - bryonia alba root - activated charcoal - lycopodium clavatum spore - sodium carbonate - strychnos nux-vomica seed - veratrum album root -).
What is the active ingredient?: Asafetida, Bismuth subnitrate, Bryonia alba root, Activated charcoal, Lycopodium clavatum spore, Sodium carbonate, Strychnos nux-vomica seed, Veratrum album root.
Who is the labeler?: TRP Company, NDC labeler code 17312. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Irritable Bowel Syndrome Therapy?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.